Innovent Announces Results of a Phase 2 Study of Picankibart (Anti-IL-23p19 Antibody) in Plaque Psoriasis, Showing Efficacy in Patients with Prior Inadequate Response to IL-17 Biologics

SAN FRANCISCO and SUZHOU,China,Oct. 29,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qu

10-29

Geotab teams up with EROAD to provide affordable solutions to fleet managers

SYDNEY,Oct. 29,2024-- Global telematics leaderGeotab has teamed up with New Zealand-based EROAD to provide powerful and affordable fleet management solutions for businesses across Australia and New Ze

10-29

SEMIFIVE Joins World Economic Forum's Global Innovators Community

SEOUL,South Korea,Oct. 29,2024-- Expected to engage in sharinginsights and connecting with public and private sector leaders to solve key issues for people and planet

10-29

Alimetry revolutionises gut health diagnosis by integrating AI into its wearable device, raises US $18m to fuel next phase of growth

MINNEAPOLIS,Oct. 29,2024-- Alimetryhas raised an oversubscribed US $18m A2 financing round to commercialise its wearable gut health monitoring device,capitalizing on increased adoption by a growing co

10-29

45 CEOs, 6 ministers and One Head of State Take the Stage at Future Investment Initiative Institute Pre Summits on Investing in Africa, and Women in Finance

RIYADH,Saudi Arabia,Oct. 29,2024-- The Future Investment Initiative Institute annual conference begins today in Riyadh,bringing together world leaders,CEOs,and executives from various sectors includin

10-29

OPEC Fund enhances global partnerships with substantial financing commitments at the 2024 World Bank meetings

Highlights: New commitments close to half a billion US dollars with Benin,Bhutan,Côte d\'Ivoire,Jordan,Oman and a bank in Uzbekistan

10-29

Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY

-- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) --

10-29

KIND Presents Positive Results of AND017 to Treat Anemia Associated with Chronic Kidney Disease in Two Phase II and Two Phase I

Clinical Trials at American Society of Nephrology (ASN) – Kidney Week 2024 SAN FRANCISCO,Oct. 29,2024-- Kind Pharmaceutical ("Hangzhou Andao Pharmaceutical Ltd. and Kind Pharmaceuticals LLC"

10-29

Hitek Global Inc. Announces First Half of Fiscal Year 2024 Financial Results

XIAMEN,China,Oct. 29,2024-- Hitek Global Inc. (Nasdaq: HKIT) (the "Company"),a China-based information technology consulting and solutions service provider,today announced its unaudited fina

10-29

Carlsberg Fully Supports Hong Kong's First Hypefest Event

Featuring a Carlsberg exclusive area on-site,with a DJ stage themed around hop leaf - immerse yourself in the strongest music vibes,and join now for a chance to win tickets and ignite your weekend fer

10-29